NEUROCRINE BIOSCIENCES, INC. (NBIX) scores 82 out of 100 on boothcheck's 11-model valuation framework. Verdict: Excellent The estimated fair value is 157.79, representing a 19% margin of safety. Quantitative score: 82/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.